Member news

Stevenage Bioscience Catalyst Board appoints Andrew Waters as Chief Executive Officer

Tangram Therapeutics announces progression to patient cohorts in Phase 1/2 RESTORE-MASH trial of TGM-312 and appointment of Dr Sonya Montgomery as Chief Development Officer

Coulter Partners successfully led a search assignment for NRG Therapeutics Ltd. and is pleased to announce the placement of Claus Sundgreen, M.D. as Chief Medical Officer (CMO).

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that it has been selected to present at a number of leading international conferences this September.

Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.

Foventa has strengthened its management team with a new CMO Dr Zaiba Malik and CFO Julia Jones as the company prepares for a Series A funding round to take lead asset FOV407 into a Phase IIb trial.

MyAmici and My Green Lab announce collaboration to support more sustainable lab purchasing. The integration helps life-science labs consider environmental impact alongside price and availability with other purchasing solutions to aid sustainability.

Imagine a world where diabetic patients no longer lose their sight. Foventa are already trialling a simple eyedrop that could make this a reality. Previously Exonate, Foventa are now Phase II ready and about to commence a Series A funding round.

LinkGevity is working with Health Innovation East, the NHS innovation arm for the East of England, to advance the clinical pathway for its first-in-class Anti-Necrotic™ therapeutic approach.

LinkGevity’s Dr Carina Kern and Serena Kern-Libera discuss new approach to age-related disease

LinkGevity CEO Dr Carina Kern contributes to new Springer Nature volume on longevity science

Initial data show that a single dose of APL-10456 was well-tolerated, highly immunogenic, and induced Th1-polarized broad cross-rhinovirus species cellular immunity.

Partnership provides US-based sequencing and scalable consumer genomics infrastructure, including an at-home DNA collection, to deliver PrecisionLife’s personalized wellness reports to US consumers.

Brainomix, a global leader in AI-powered imaging for stroke and lung disease, today announced that five abstracts showcasing its proprietary biomarkers and advanced CT analysis technologies will be presented at the European Respiratory Society (ERS) Congress 2026, taking place September 5–9 in Barcelona, Spain.

Space is pushing the limits of human biology & any breakthroughs there may transform medicine on Earth.

LinkGevity featured on BBC News

LinkGevity CEO Dr. Carina Kern joined other global leaders across biotech, medicine, AI, and consumer health at Milken Institute Global Conference to discuss the next phase of longevity science and healthy aging.

NRG Therapeutics presented a poster on preclinical and mechanistic data of its lead clinical asset NRG5051.

Opening for participation on September 2nd 2026, PIR International’s 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study will provide a comprehensive, data-driven view of board remuneration, composition and diversity across the European and UK life sciences sector.

Agilent Technologies has been announced as a founding member of Harwell’s new CO:LABS development.